Category Archives: Protest&Campaigns

Reminder! Register for panel event WHA72 Friday , 24 May on CART and CRISPR

Source: Keionline 21st May, 2019   24 May 2019- KEI panel discussion- Assessing the implications of the development of new cell and gene-based therapies (including CART and CRISPR): What role should WHO play? On Friday, 24 May 2019, Knowledge Ecology International … Continue reading

Posted in Access to Medicins, IP Rights, Upcoming events | Leave a comment

RCEP and affordable medicines: Civil society reaches out to Minister of Commerce Suresh Prabhu

12th Nov 2018, New Delhi The RCEP ministerial meeting is taking place today, 12th November, 2018 in Singapore. It will be followed by Leaders’ Summit on 14th November. There are clear indications that countries want to wrap up the negotiations that started in … Continue reading

Posted in Fix the patent law, IPR policy, Regional Comprehensive Economic Partnership | Leave a comment

Most New Drug Patents Are for Old Remedies, Research Shows

Source: Bloomberg | November 1, 2018 The U.S. patent system was designed to protect new innovations, but drugmakers are more often than not using it to protect old ones. At least 74 percent of drugs associated with new patents were medicines … Continue reading

Posted in Fix the patent law, Patent, Patent Enforcement, Patent Term Extension | Leave a comment

New laws needed now to save lives: FTPL statement on new IP policy

  Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading

Posted in Compulsory Licensing, Doha Declaration, Fix the patent law, Patent Opposition, Patent Term Extension, TRIPS, Uncategorized | Leave a comment

Patients Over Profits: Families Unite to Fight for Healthcare and Justice

Source: The Wire | May 27, 2018 New Delhi: Tragedies can be tipping points for change. And through their bereavements, four families have come together to demand accountability and change from the government as well as from private hospitals. They are … Continue reading

Posted in Letters to officials, Right to Health | Leave a comment

South African Cabinet approves new Intellectual Property Policy

Source: Fix the Patent Laws | May 24, 2018 The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of … Continue reading

Posted in Africa, Fix the patent law, IPR policy, Patent, Uncategorized | Leave a comment

Report on Pharmaceutical Patents in India – How our safeguards against evergreening have failed, and why the system must be reformed

  The recent report on “Pharmaceutical Patent Grants in India How our safeguards against evergreening have failed, and why the system must be reformed” shows immense irregularities in grant of patents in the country. Over the past decades India’s patent system has … Continue reading

Posted in Evergreening, Fix the patent law, India, Indian Patent Law, Indian Patent Office | Leave a comment

72% of drug patent grants in India for marginal improvements, says study

Source: Business Today | April 25, 2018 Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals. The report which studied the prosecution history of … Continue reading

Posted in Fix the patent law, India, Indian Patent Law, Indian Patent Office, Uncategorized | Leave a comment

Scottish Compulsory Licensing campaign launches today

Highlighting a new campaign aimed at the Scottish government on the price of Roche’s pertuzumab for breast cancer Dunise is a Scottish woman with breast cancer. Right now she is getting access to a drug pertuzumab (Perjeta) because she live in England.

Posted in Cancer, Drug prices, Protest&Campaigns, Uncategorized, Upcoming events | Leave a comment

Roche vs Indian Pharma: The battle for a cheaper cancer drug

By Divya Rajagopal, The Economic Times|May 14, 2017 Let’s hark back to the Nineties. The HIV-AIDS epidemic was spreading across Africa, leaving thousands dead, in spite of the existence of anti-retroviral drugs (ARVs). The cost of the treatment, around $10,000, … Continue reading

Posted in Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer, Uncategorized | Leave a comment